Diagnolita is a Lithuanian medical diagnostics company that provides a non-invasive molecular diagnostic test for prostate cancer. The test is based on quantification of two prostate cancer biomarkers in voided urine with or without prostate massage. The test is significantly more informative than the traditional PSA based one, and could help avoiding unnecessary biopsy in many cases. During Covid19 pandemics Diagnolita has developed noninvasive saliva Covid19 PCR test and provides diagnostics service.

• Estonia
• Latvia
• Poland

• 0.5M-1M Turnover, €
• 1-9 Employees
• 2013Year of establishment

Prostate cancer diagnostics, saliva diagnostics, Covid-19, coronavirus

• https://www.vaspvt.gov.lt/vaspvt/m/m_files/Lic/L4013.pdf